Enovis (ENOV) Competitors $31.41 -0.90 (-2.79%) Closing price 03:59 PM EasternExtended Trading$31.48 +0.08 (+0.25%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ENOV vs. STVN, GKOS, NARI, INSP, BLCO, SLNO, IRTC, PRCT, NVST, and TMDXShould you be buying Enovis stock or one of its competitors? The main competitors of Enovis include Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), Inspire Medical Systems (INSP), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), iRhythm Technologies (IRTC), PROCEPT BioRobotics (PRCT), Envista (NVST), and TransMedics Group (TMDX). These companies are all part of the "medical equipment" industry. Enovis vs. Stevanato Group Glaukos Inari Medical Inspire Medical Systems Bausch + Lomb Soleno Therapeutics iRhythm Technologies PROCEPT BioRobotics Envista TransMedics Group Enovis (NYSE:ENOV) and Stevanato Group (NYSE:STVN) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, media sentiment, institutional ownership, dividends, valuation, earnings and community ranking. Which has better earnings & valuation, ENOV or STVN? Stevanato Group has lower revenue, but higher earnings than Enovis. Enovis is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnovis$2.11B0.86-$33.26M-$14.29-2.22Stevanato Group$1.10B6.08$157.62M$0.4846.21 Which has more volatility and risk, ENOV or STVN? Enovis has a beta of 1.86, meaning that its stock price is 86% more volatile than the S&P 500. Comparatively, Stevanato Group has a beta of 0.52, meaning that its stock price is 48% less volatile than the S&P 500. Is ENOV or STVN more profitable? Stevanato Group has a net margin of 10.47% compared to Enovis' net margin of -5.95%. Stevanato Group's return on equity of 9.86% beat Enovis' return on equity.Company Net Margins Return on Equity Return on Assets Enovis-5.95% 4.39% 2.80% Stevanato Group 10.47%9.86%5.79% Does the media refer more to ENOV or STVN? In the previous week, Enovis and Enovis both had 5 articles in the media. Stevanato Group's average media sentiment score of 1.22 beat Enovis' score of 0.59 indicating that Stevanato Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Enovis 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Stevanato Group 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer ENOV or STVN? Enovis currently has a consensus price target of $58.50, suggesting a potential upside of 84.19%. Given Enovis' stronger consensus rating and higher possible upside, equities analysts clearly believe Enovis is more favorable than Stevanato Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Enovis 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75Stevanato Group 0 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.71 Does the MarketBeat Community believe in ENOV or STVN? Enovis received 2 more outperform votes than Stevanato Group when rated by MarketBeat users. Likewise, 64.00% of users gave Enovis an outperform vote while only 62.50% of users gave Stevanato Group an outperform vote. CompanyUnderperformOutperformEnovisOutperform Votes3264.00% Underperform Votes1836.00% Stevanato GroupOutperform Votes3062.50% Underperform Votes1837.50% Do insiders & institutionals believe in ENOV or STVN? 98.4% of Enovis shares are held by institutional investors. 2.4% of Enovis shares are held by insiders. Comparatively, 0.7% of Stevanato Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. SummaryStevanato Group beats Enovis on 9 of the 17 factors compared between the two stocks. Remove Ads Get Enovis News Delivered to You Automatically Sign up to receive the latest news and ratings for ENOV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ENOV vs. The Competition Export to ExcelMetricEnovisSurgical appliances & supplies IndustryMedical SectorNYSE ExchangeMarket Cap$1.81B$8.60B$5.33B$18.54BDividend YieldN/A1.71%5.11%4.24%P/E Ratio-14.5018.5421.8031.15Price / Sales0.8672.53377.9325.48Price / Cash6.8619.6738.1517.54Price / Book0.514.856.434.30Net Income-$33.26M$284.66M$3.20B$1.02B7 Day Performance3.81%5.38%6.37%6.53%1 Month Performance-14.19%-2.43%-8.70%-6.93%1 Year Performance-44.10%-21.64%10.26%1.22% Enovis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ENOVEnovis2.2051 of 5 stars$31.41-2.8%$58.50+86.3%-44.9%$1.79B$2.11B-14.346,800STVNStevanato Group1.7277 of 5 stars€19.23+1.1%N/A-24.1%$5.82B$1.10B40.914,650Positive NewsGap DownGKOSGlaukos4.5745 of 5 stars$85.87+2.7%$163.25+90.1%-5.3%$4.86B$383.48M-29.92780Analyst ForecastHigh Trading VolumeNARIInari Medical0.3501 of 5 stars$79.97flat$68.00-15.0%N/A$4.68B$493.63M-59.24800INSPInspire Medical Systems4.6374 of 5 stars$149.72+5.5%$226.70+51.4%-35.4%$4.46B$802.80M86.541,246Analyst ForecastPositive NewsGap DownBLCOBausch + Lomb3.8673 of 5 stars$11.86-2.1%$18.82+58.7%-14.0%$4.18B$4.79B-13.0312,500Gap DownSLNOSoleno Therapeutics4.7854 of 5 stars$69.64+3.2%$99.63+43.1%+88.5%$3.19BN/A-20.9830Analyst ForecastPositive NewsHigh Trading VolumeIRTCiRhythm Technologies0.8961 of 5 stars$100.17-0.2%$119.73+19.5%-8.8%$3.15B$591.84M-27.521,790Positive NewsPRCTPROCEPT BioRobotics2.3993 of 5 stars$50.83-0.8%$94.29+85.5%+6.0%$2.79B$224.50M-26.07430Positive NewsGap DownHigh Trading VolumeNVSTEnvista4.3962 of 5 stars$15.27-1.4%$20.18+32.2%-18.5%$2.63B$2.51B-2.3512,700Analyst ForecastAnalyst RevisionNews CoveragePositive NewsGap DownTMDXTransMedics Group2.7651 of 5 stars$69.15+2.2%$122.70+77.4%-5.4%$2.33B$441.54M73.56210 Remove Ads Related Companies and Tools Related Companies Stevanato Group Competitors Glaukos Competitors Inari Medical Competitors Inspire Medical Systems Competitors Bausch + Lomb Competitors Soleno Therapeutics Competitors iRhythm Technologies Competitors PROCEPT BioRobotics Competitors Envista Competitors TransMedics Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ENOV) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enovis Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enovis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
